Silence Therapeutics plc
NASDAQ:SLN · NASDAQ Global Market
+$0.19 today
Vol 0.38M · Avg 0.31M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+20.10%
Period High
$7.97
Period Low
$4.30
Latest
$6.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.30B
Alto Neuroscience, Inc.
NYSE:ANRO
$782.59M
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$443.03M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$389.86M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$348.58M
Amarin Corporation plc
NASDAQ:AMRN
$332.17M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$292.84M
AC Immune S.A.
NASDAQ:ACIU
$241.71M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.02M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.52M
What is the latest SLN filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does SLN have?
Intrinsic Alpha currently shows 20 recent filings for SLN.
Explore More
Continue the stock analysis
Jump to another research area for this company.